Latest News

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Hollings is a pilot site for an American Cancer Society program to train college students to navigate patients to needed resources.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

The National Cancer Institute renewed MUSC Hollings Cancer Center's NCI designation, awarding the center its best score ever of “outstanding performance.”

Is there a role for e-cigarettes among adults who have not been able to stop using combustible cigarettes after using FDA-approved medication?

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Three MUSC occupational therapy students are passionate about elevating the profession's role in cancer care.

Two MUSC researchers think that community libraries could hold the potential to improve head and neck cancer awareness.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.